ARISE - Advanced RNA Inhalation Solutions anchored in Evolved dry powder technology.

Project Information

ARISE

Grant agreement ID: 101215031

DOI

10.3030/101215031

EC signature date 18 March 2025

Start date 1 April 2025

End date 31 March 2028

Funded under

• The European Innovation Council (EIC)

Total cost

No data

EU contribution

€ 2 421 498,75

Coordinated by

RNhale GmbH
Germany

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (1)

Understanding excipient interactions unlocks untapped potential of RNA-lipid nanoparticles in dry powder formulations for local pulmonary delivery

Author(s): Nora Martini, Leonie Deßloch, Taras Sych, Otto Berninghausen, J. Merl-Pham, Sjoerd Dijkstra, Simone P. Carneiro, Marion Frankenberger, Roland Beckmann, Jürgen Behr, Gabriele Matschiner, Christine Schuberth-Wagner, A. Önder Yildirim, David C. Jürgens, Erdinc Sezgin, Olivia M. Merkel, Benjamin Winkeljann
Published in: Journal of Controlled Release, Issue 390, 2026, ISSN 0168-3659
Publisher: Elsevier BV
DOI: 10.1016/J.JCONREL.2025.114539